DIA Global Annual Meeting 2026

June 14-18,2026
Philadelphia, PA

Event: DIA Global Annual Meeting 2026

Date: June 14-18,2026

Location: Pennsylvania Convention Center, 1101 Arch St. Philadelphia, PA


DIA 2026 Global Annual Meeting: New Energy, Proven Impact

DIA 2026 (June 14-18, Philadelphia) reimagines the flagship event with innovative formats to accelerate therapeutic development. Key highlights include:
  • New LIFT Series: Dedicated programming for biotech startups to connect with investors and mentors.

  • Daily Plenary Sessions: Inspiring morning sessions featuring visionary leaders and patient advocates.

  • Enhanced Learning: 10 refreshed content tracks, interactive problem-solving workshops, and intensive short courses.

  • The Exchange: A reimagined exhibit hall featuring Innovation Theaters, Content Hubs, and live demonstrations.

  • Networking & Research: New Wednesday Night Celebration, professional/student poster competitions, and intimate roundtable discussions.

  • Focused Pathways: Deep-dive sessions on high-impact areas like Obesity and Oncology.


Booth Number: 1303


Presentation from AlphaLife Sciences:

Date: June 15

Time:  12:25- 12:55PM ET

Speakers:

-Sharon Chen, Founder and CEO, AlphaLife Sciences

-Cieayrra Boozer, Product Specialist, AlphaLife Sciences

Session type:  Innovation Hub

Topic:AI-Augmented Lifecycle: From Study Design to eCTD-Ready Submission — Featuring AI Tools Demo


Abstract:

This session demonstrates AI across two stages of drug development. Part 1 — AI-augmented Study Startup: from Study Design SSOT through Protocol writing to ICF, showing how AI accelerates upstream design and authoring. Part 2 — AI-orchestrated Authoring and QC across the eCTD document network: from M2.7.3 and M2.7.4 Clinical Summaries to Labeling, and from CMC Module 3 to Labeling — accelerating NDA submission. Through live demos, we show how AI discovers cross-document relationships, propagates upstream changes semantically, and delivers submission-ready coherence with a complete audit trail.

1. AI-Augmented Study Startup: From Study Design SSOT, AI assists design and one-click generates synchronized Protocol and ICF — with rationale captured.

2. AI-Orchestrated Authoring & QC Across the eCTD Network: AI discovers cross-document relationships and propagates content across M2.7.3, M2.7.4, CMC Module 3, and Labeling.

3. The Document Network Effect: Change Intelligence and complete audit trails turn connected documents into a faster, regulatory-ready NDA submission.


To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.


Schedule a Meeting with Us

This is a required field.

By submitting this form, I accept to receive communications from AlphaLife Sciences in accordance with the Terms of our Privacy Policy

Thank You!

Thank you for requesting a meeting with our team! A representative will be in contact soon to schedule a convenient time.

Back Home